Yousefi, B., N. Samadi, B. Baradaran, V. Rameshknia, V. Shafiei-Irannejad, M. Majidinia, N. Targhaze, and N. Zarghami. “Differential Effects of Peroxisome Proliferator-Activated Receptor Agonists on Doxorubicin-Resistant Human Myelogenous Leukemia (K562/DOX) Cells”. Cellular and Molecular Biology, vol. 61, no. 8, Dec. 2015, pp. 118-22, https://mail.cellmolbiol.org/index.php/CMB/article/view/768.